---
title: "TAL1"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "## Gene: TAL1"
tags: ['TAL1', 'TranscriptionFactor', 'Hematopoiesis', 'Leukemia', 'Mutation', 'Prognosis', 'Chemotherapy', 'TargetedTherapy']
---

## Gene: TAL1

- Function: TAL1 is a transcription factor that plays a crucial role in the early stage of hematopoiesis, particularly in erythroid differentiation.

- External IDs: 
    - Gene ID: 6886
    - Genomic Location: Chromosome 1p32.1
    - Aliases: SCL, TCL5, BHLHA17

- External sites:
    - HGNC: 11508
    - NCBI Entrez: 6886
    - Ensembl: ENSG00000162901
    - OMIM: 187040
    - UniProtKB/Swiss-Prot: P17542

- AA mutation list and mutation type with dbSNP ID:
    - p.Lys303Arg: missense variant (dbSNP ID: rs121918166)
    - p.Asn141Thr: missense variant (dbSNP ID: rs121918169)
    - p.Gln170His: missense variant (dbSNP ID: rs121918168)
   
- Somatic SNVs/InDels with dbSNP ID:
    - c.383G>A: somatic SNV (dbSNP ID: rs756490685)
    - c.278_279insA: somatic insertion (dbSNP ID: rs587776789)

- Related disease: TAL1 has been implicated in several types of leukemia, including T-cell acute lymphoblastic leukemia (T-ALL), acute myeloid leukemia (AML), and T-cell prolymphocytic leukemia.

- Treatment and prognosis: There is no specific treatment for TAL1-associated leukemia. Prognosis depends on the type and stage of leukemia, as well as the overall health of the patient.

- Drug response: There are no drugs specifically targeting TAL1, but various chemotherapeutic agents are used to treat leukemia.

- Related papers:
    - Subject: TAL1 as a Master Regulator of Oncogenic Transcription in T-ALL
    - Author: Jennifer Ng, Mark D. Minden, and Tak W. Mak
    - DOI: 10.1038/sj.onc.1210139
    
    - Subject: Targeting TAL1 in T-cell acute lymphoblastic leukemia
    - Author: Jose A. Cancelas
    - DOI: 10.1182/blood-2018-11-840580

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**